Diverse Biotech Inc. Initiates Regulation D Private Placement to Fund Accelerated Development of new Antibiotic Class
Diverse Biotech Inc., a pioneering biopharmaceutical company dedicated to addressing significant unmet medical needs, today announced the initiation of a Regulation D Private Placement offering for accredited investors.










